Blue-Chip Stock Lower on Slashed Full-Year Outlook — Negative

SHW   Schaeffers Research — July 22, 2025

Dow Jones Industrial Average (DJI) member Sherwin-Williams Co (NYSE:SHW) reported a second-quarter profit miss of $3.38 per share earlier, while revenue came in slightly above estimates at $6.3 billion.

image for news Blue-Chip Stock Lower on Slashed Full-Year Outlook

GM's Earnings Are a Warning Sign as August Tariff Deadline Looms — Negative

GM   Barrons — July 22, 2025

Profit margins for the auto maker's North American business were 4.8%, down nearly five percentage points from the second quarter last year.

image for news GM's Earnings Are a Warning Sign as August Tariff Deadline Looms

RACINE, Wis., July 22, 2025 (GLOBE NEWSWIRE) -- J OHNSON O UTDOORS I NC . (Nasdaq: JOUT), a leading global innovator of outdoor recreation equipment and technology, will release financial results for the Fiscal 2025 third quarter on Friday, August 1, 2025, before market open that day. The Company will host a conference call and audio webcast shortly afterwards at 11:00 a.m. Eastern Time to discuss the financial results and provide a Company update.

image for news Johnson Outdoors to Release Fiscal 2025 Third Quarter Results on August 1, 2025

DALLAS--(BUSINESS WIRE)--AECOM (NYSE: ACM) today announced that its previously announced cash tender offer (the “Tender Offer”) for any and all of its 5.125% senior notes due 2027 (the “Notes”) expired at 5:00 p.m. New York City time, on July 21, 2025 (the “Expiration Date”). According to information provided by D.F. King and Co., Inc., the Tender and Information Agent for the Tender Offer, $732,914,000 aggregate principal amount of the Notes, or 73.49% of the aggregate principal amount outstan.

image for news AECOM announces expiration and results of offer to purchase 5.125% Senior Notes due 2027

How Will AbbVie's Neuroscience Franchise Perform in Q2 Earnings? — Positive

ABBV   Zacks Investment Research — July 22, 2025

ABBV's neuroscience sales are projected to jump 15% in Q2, driven by Botox Therapeutic, Vraylar and oral migraine drug gains.

image for news How Will AbbVie's Neuroscience Franchise Perform in Q2 Earnings?

SRPT Slides on Voluntary US Elevidys Shipment Pause Amid Scrutiny — Negative

SRPT   Zacks Investment Research — July 22, 2025

Sarepta stock down as it halts U.S. Elevidys shipments after FDA pressure and safety concerns tied to patient deaths due to liver failure.

image for news SRPT Slides on Voluntary US Elevidys Shipment Pause Amid Scrutiny

Applied Materials (AMAT) Recently Broke Out Above the 20-Day Moving Average — Positive

AMAT   Zacks Investment Research — July 22, 2025

After reaching an important support level, Applied Materials (AMAT) could be a good stock pick from a technical perspective. AMAT surpassed resistance at the 20-day moving average, suggesting a short-term bullish trend.

image for news Applied Materials (AMAT) Recently Broke Out Above the 20-Day Moving Average

North American Construction (NOA) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

image for news North American Construction (NOA) Loses 8.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Here's Why CVS Health (CVS) is Poised for a Turnaround After Losing 7.7% in 4 Weeks — Neutral

CVS   Zacks Investment Research — July 22, 2025

CVS Health (CVS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

image for news Here's Why CVS Health (CVS) is Poised for a Turnaround After Losing 7.7% in 4 Weeks

Steris (STE) Loses 6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner — Negative

STE   Zacks Investment Research — July 22, 2025

Steris (STE) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

image for news Steris (STE) Loses 6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Auto Stock Eyes Worst Day Since March After Earnings — Negative

GM   Schaeffers Research — July 22, 2025

General Motors Co (NYSE:GM) stock is down 7% at $49.58 this morning, sliding lower despite the vehicle manufacturer's second-quarter earnings and revenue beat.

image for news Auto Stock Eyes Worst Day Since March After Earnings

American Tower to Report Q2 Earnings: What to Expect From the Stock? — Positive

AMT   Zacks Investment Research — July 22, 2025

AMT's Q2 results may show revenue and AFFO declines, but strength in services and data centers may have offered support.

image for news American Tower to Report Q2 Earnings: What to Expect From the Stock?

Brokers Suggest Investing in Zscaler (ZS): Read This Before Placing a Bet — Negative

ZS   Zacks Investment Research — July 22, 2025

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

image for news Brokers Suggest Investing in Zscaler (ZS): Read This Before Placing a Bet

Invesco (IVZ) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates — Positive

IVZ   Zacks Investment Research — July 22, 2025

Although the revenue and EPS for Invesco (IVZ) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

image for news Invesco (IVZ) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

Wall Street Bulls Look Optimistic About AZZ (AZZ): Should You Buy? — Positive

AZZ   Zacks Investment Research — July 22, 2025

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

image for news Wall Street Bulls Look Optimistic About AZZ (AZZ): Should You Buy?

Here's What Key Metrics Tell Us About Equifax (EFX) Q2 Earnings — Neutral

EFX   Zacks Investment Research — July 22, 2025

While the top- and bottom-line numbers for Equifax (EFX) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

image for news Here's What Key Metrics Tell Us About Equifax (EFX) Q2 Earnings

Brokers Suggest Investing in Cadence (CDNS): Read This Before Placing a Bet — Negative

CDNS   Zacks Investment Research — July 22, 2025

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

image for news Brokers Suggest Investing in Cadence (CDNS): Read This Before Placing a Bet

Peoples Bancorp (PEBO) Reports Q2 Earnings: What Key Metrics Have to Say — Positive

PEBO   Zacks Investment Research — July 22, 2025

The headline numbers for Peoples Bancorp (PEBO) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

image for news Peoples Bancorp (PEBO) Reports Q2 Earnings: What Key Metrics Have to Say

Earnings Growth & Price Strength Make Huntington Ingalls (HII) a Stock to Watch — Positive

HII   Zacks Investment Research — July 22, 2025

The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.

image for news Earnings Growth & Price Strength Make Huntington Ingalls (HII) a Stock to Watch

Is It Worth Investing in Comfort Systems (FIX) Based on Wall Street's Bullish Views? — Neutral

FIX   Zacks Investment Research — July 22, 2025

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

image for news Is It Worth Investing in Comfort Systems (FIX) Based on Wall Street's Bullish Views?